Positive results for anifrolumab in phase III SLE trial

被引：6
|
作者：
Onuora, Sarah
机构：
[1] Nature Reviews Rheumatology,
来源：
NATURE REVIEWS RHEUMATOLOGY | 2020年 / 16卷 / 03期
关键词：
D O I：
10.1038/s41584-020-0384-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [31] Efficacy of Anifrolumab in Serological Subgroups of Patients with SLE Participating in 2 Phase 3 Trials
    Bruce, Ian N.
    Van Vollenhoven, Ronald
    Tanaka, Yoshiya
    Morand, Eric
    Furie, Richard
    Psachoulia, Konstantina
    Maho, Emmanuelle
    Lindholm, Catharina
    Kleoudis, Christi
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3631 - 3633
  • [32] The potential of dabrafenib to treat BRAF-positive melanoma: results from a recent Phase III trial
    O'Hare, Alice
    PHARMACOGENOMICS, 2012, 13 (12) : 1326 - 1326
  • [33] Anifrolumab Results in Favorable Responses Regardless of SLE Disease Duration: Post Hoc Analysis of Data from 2 Phase 3 Trials
    Kalunian, Kenneth
    Dall'Era, Maria
    Furie, Richard
    Morand, Eric
    Psachoulia, Konstantina
    Maho, Emmanuelle
    Lindholm, Catharina
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3629 - 3631
  • [34] Positive results found in Phase IIa asthma trial
    不详
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (02) : 141 - 141
  • [35] Herpes Zoster Events with Anifrolumab in Patients with Active SLE: An Integrated Analysis of Phase 2 and Phase 3 Trials
    Merrill, Joan
    Kalunian, Kenneth
    Furie, Richard
    Winthrop, Kevin
    Primakov, Patricia
    Pineda, Lilia
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [36] Positive efficacy results obtained in phase II trial of ALX1-11; Phase III trials to begin soon
    不详
    DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 506 - 506
  • [37] RELATIONSHIP OF ANIFROLUMAB PK WITH EFFICACY AND SAFETY IN PATIENTS WITH SLE
    Chia, Y. L.
    Zhang, J.
    Tummala, R.
    Rouse, T.
    Furie, R.
    Morand, E. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 587 - 588
  • [38] Positive Phase III results with Avastin in breast cancer patients
    不详
    IMMUNOTHERAPY, 2009, 1 (01) : 13 - 13
  • [39] Association of Smoking and Cutaneous Manifestations in Systemic Lupus Erythematosus (SLE): Post-Hoc Results from Phase IIb Studies of Anifrolumab and Sifalimumab
    Werth, Victoria P.
    Illei, Gabor
    Abreu, Gabriel
    Wang, Liangwei
    Greth, Warren
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials
    Bruce, Ian N.
    van Vollenhoven, Ronald F.
    Psachoulia, Konstantina
    Lindholm, Catharina
    Maho, Emmanuelle
    Tummala, Raj
    LUPUS SCIENCE & MEDICINE, 2023, 10 (01):
12345